Pharmaceutical - Priaxon

Filter

Current filters:

Priaxon

Popular Filters

Amgen in $180 mill deal with BIND; Priaxon accord with GlaxoSmithKline

09-01-2013

BIND Biosciences, a US clinical stage investor backed company, and Amgen (Nasdaq: AMNG), the world's…

AmgenBIND BiosciencesBiotechnologyGlaxoSmithKlineLicensingOncologyPharmaceuticalPriaxon

Back to top